Lux Health Tech Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire companies in the healthcare and technology industries. The company was incorporated in 2020 and is based in New York, New York.

Lux Health Tech Acquisition Corp.

Lux Capital is a venture capital firm that makes long-term bets on contrarians and outsiders. We believe the next generation of industrialist titans will be scientists, technologists and inventors who are doing more than challenging the status quo—they’re literally challenging the laws of physics. We have offices in New York City and Menlo Park.Over the past two decades, Lux has expanded from our New York City roots to Silicon Valley, and built an over $5 billion AUM firm of more than 30 full-time professionals, with a wide spectrum of technical backgrounds and the versatility to invest at any stage, from $100,000 to $100 million.We invest in seed- and early-stage ventures across multiple sectors, including: 3D printing; machine learning; artificial intelligence; flying robots; surgical robots; synthetic biology; genomics; satellites; space; drones; computational imaging and recognition; new materials; holograms; “fixers” for the future; the internet of things; connected hardware; the smart home and virtual reality.

Zoox

Genocea Biosciences

Aeva

Aira

Auris Health

Tactic

Tempo Automation

Thrive Earlier Detection

Transphorm

CTRL-labs

Desktop Metal

Kala Pharmaceuticals

Latch

Matterport

Evolv Technology

Rigetti Computing

Science 37

Senti Biosciences

AirMap

Planet

Yonder

AltspaceVR

Shapeways

Recursion Pharmaceuticals

Resilience

Lux Capital

	Dec '20	Dec '21
average inventory
average payables		138.12K -
average receivables
book value per share	9.68 -	9.20 4.89%
capex per share
capex to depreciation
capex to operating cash flow
capex to revenue
cash per share	0.02 -	0.01 34.49%
days of inventory on hand
days payables outstanding
days sales outstanding
debt to assets	0.04 -	0.08 129.92%
debt to equity	0.04 -	0.09 141.44%
dividend yield
earnings yield	-0.00 -	1.84 65,824.07%
enterprise value	85.27M -	30.08M 64.72%
enterprise value over ebitda	-348.42 -	1.11 100.32%
ev to operating cash flow		-42.69 -
ev to sales
free cash flow per share		-0.02 -
free cash flow yield		-0.02 -
graham net net	-0.34 -	-0.80 138.65%
graham number	1.23 -	18.23 1,377.90%
income quality		-0.03 -
intangibles to total assets	0 -	0
interest coverage	69.51 -	0.04 99.94%
interest debt per share	-0.00 -	-0.81 778,072.98%
inventory turnover
invested capital		0.00 -
market cap	85.91M -	30.02M 65.06%
net current asset value	-11.18M -	-27.51M 146.11%
net debt to ebitda	2.61 -	0.00 99.91%
net income per share	-0.01 -	1.61 23,063.83%
operating cash flow per share		-0.02 -
payables turnover
receivables turnover
research and ddevelopement to revenue
return on tangible assets	-0.00 -	0.16 23,091.11%
revenue per share
roe	-0.00 -	0.17 24,243.55%
roic	-0.00 -	-0.01 888.38%
sales general and administrative to revenue
shareholders equity per share	9.68 -	9.20 4.89%
stock based compensation to revenue
tangible asset value	333.83M -	317.51M 4.89%
tangible book value per share	9.68 -	9.20 4.89%
working capital	896.47K -	-269.81K 130.10%

NASDAQ:LUXA

Lux Capital

Last Close

10.04

28/10 20:00

Volume Today

2.48M

Avg: 203.47K

PE Ratio

17.20

PFCF: -